NO133838B - - Google Patents
Download PDFInfo
- Publication number
- NO133838B NO133838B NO901/71A NO90171A NO133838B NO 133838 B NO133838 B NO 133838B NO 901/71 A NO901/71 A NO 901/71A NO 90171 A NO90171 A NO 90171A NO 133838 B NO133838 B NO 133838B
- Authority
- NO
- Norway
- Prior art keywords
- magnesium
- acid
- skin
- hair
- compounds
- Prior art date
Links
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 210000004209 hair Anatomy 0.000 claims description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000003883 ointment base Substances 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 7
- 239000013522 chelant Substances 0.000 description 5
- 150000002681 magnesium compounds Chemical class 0.000 description 4
- 159000000003 magnesium salts Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- -1 MgCl2 Chemical class 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH359870A CH533639A (de) | 1970-03-11 | 1970-03-11 | Verfahren zur Herstellung neuer Benzo(4,5)cyclohepta(1,2-b)-thiophen-Derivate |
| CH1159370A CH531000A (de) | 1970-03-11 | 1970-07-31 | Verfahren zur Herstellung neuer Benzocycloheptathiophene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO133838B true NO133838B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-03-29 |
| NO133838C NO133838C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-07-07 |
Family
ID=25693399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90171A NO133838C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-03-11 | 1971-03-10 |
Country Status (16)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2243778T3 (en) | 2008-01-30 | 2014-11-17 | Nippon Zoki Pharmaceutical Co | piperidine |
-
1971
- 1971-03-05 SU SU1628614A patent/SU512711A3/ru active
- 1971-03-09 PL PL14675171A patent/PL84083B1/pl unknown
- 1971-03-09 HU HUSA002175 patent/HU162868B/hu unknown
- 1971-03-09 YU YU58671A patent/YU35019B/xx unknown
- 1971-03-09 ES ES389044A patent/ES389044A1/es not_active Expired
- 1971-03-09 FI FI68371A patent/FI52980C/fi active
- 1971-03-09 CS CS171771A patent/CS185562B2/cs unknown
- 1971-03-09 IL IL36370A patent/IL36370A/xx unknown
- 1971-03-10 BG BG017004A patent/BG22398A3/xx unknown
- 1971-03-10 DK DK111471A patent/DK134404B/da not_active IP Right Cessation
- 1971-03-10 DD DD16465971A patent/DD100000A5/xx unknown
- 1971-03-10 JP JP46013021A patent/JPS5217030B1/ja active Pending
- 1971-03-10 NO NO90171A patent/NO133838C/no unknown
- 1971-03-10 IE IE29971A patent/IE34997B1/xx unknown
-
1973
- 1973-06-30 ES ES416480A patent/ES416480A1/es not_active Expired
-
1974
- 1974-07-15 IE IE741494A patent/IE34998L/xx unknown
-
1978
- 1978-03-24 YU YU69978A patent/YU35254B/xx unknown
- 1978-09-15 IT IT7827770A patent/IT7827770A0/it unknown
-
1983
- 1983-12-30 MY MY8300201A patent/MY8300201A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU628673B2 (en) | Process for preparing an effervescent aqueous solution having an emollient action on the cuticle of the nails, composition for carrying out the said process and corresponding cosmetic treatment | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| MX2009012742A (es) | Ingrediente activo novedoso en cicatrizacion y uso del mismo. | |
| MX2014015799A (es) | Composiciones farmaceuticas que comprenden rifaximina y aminoacidos, metodo de preparacion y uso de las mismas. | |
| WO2020147511A8 (zh) | 赤红球菌产品在治疗温血动物的皮肤损伤或溃疡中的用途 | |
| WO2016079912A1 (ja) | 毛乳頭細胞活性化剤 | |
| NO133838B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR20120113262A (ko) | 색소 침착 예방 또는 개선제 | |
| ZA202204665B (en) | Hydrogel based on zinc gluconate and hyaluronic acid esters | |
| NO20011091L (no) | Umettede hydroksiminsyrederivater som PARP inhibitorer | |
| CH609863A5 (en) | Cosmetic treatment process and products enabling it to be carried out | |
| MX169354B (es) | Procedimiento para el tratamiento de pieles | |
| DE10393402T5 (de) | Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen | |
| US2303765A (en) | Preparation of ammonium allantoinate | |
| DE102010015120B4 (de) | Verwendung eines proteasehaltigen Haarwuchsreduktionsmittels | |
| WO2005016297A1 (es) | Regenerador capilar | |
| ES2055551T3 (es) | Composicion farmaceutica en forma de suspension acuosa estable a base de sucralfato y de una substancia antiacido asi como su procedimiento de preparacion. | |
| WO2025017299A1 (en) | Hydrogen sulphide for topical treatment of nail infection | |
| KR20160055720A (ko) | 위생제품, 의약품 및 화장품 제조에 활용될 수 있는 단백질 보존 및 안정화 방법 | |
| KR20250005307A (ko) | 콜라겐 마이크로니들 제제 | |
| JPS54100318A (en) | Aliphatic acid and aspartic acid ester of glycerine, its preparation, and amphoteric surfactant containing it as active component | |
| EP3052475B1 (en) | Pharmaceutical use of 3-benzylsulfonylpropionitrile | |
| LOMBART et al. | JP BOREL, A. VIEILLARD | |
| EP3549638A3 (en) | Pharmaceutical composition for use in treating an age-associated condition | |
| KR790000168B1 (en) | Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4'-halo-anilides and pharmaceutical compositions |